Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene

被引:37
作者
Marcon, G
Giaccone, G
Cupidi, C
Balestrieri, M
Beltrami, CA
Finato, N
Bergonzi, P
Sorbi, S
Bugiani, O
Tagliavini, F
机构
[1] Ist Nazl Neurol Carlo Besta, Div Neuropathol, I-20133 Milan, Italy
[2] Univ Udine, DPMSC, Dept Neurol, I-33100 Udine, Italy
[3] Univ Udine, DPMSC, Dept Psychiat, I-33100 Udine, Italy
[4] Univ Udine, DIRM, Dept Pathol, I-33100 Udine, Italy
[5] Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy
关键词
A beta; Alzheimer disease; ectopic neurons; epilepsy; ghost tangles; mutation; presenilin; 2;
D O I
10.1093/jnen/63.3.199
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Presenilin 1 and 2 are 2 highly homologous genes involved in familial Alzheimer disease. While more than 100 mutations in presenilin I are known to segregate with the disease in familial Alzheimer disease, only 9 mutations of presenilin 2 have been identified to date. We report the clinical and neuropathological phenotype of FLO10, the large Italian Alzheimer kindred associated with methionine to valine substitution at residue 239 of presenilin 2. The patients showed a remarkable variability in age of onset of symptoms, disease duration, and clinical presentation. The neuropathological study of 2 patients revealed peculiar features in addition to neurofibrillary changes and Abeta amyloid deposits in the neuropil and vessel wall. Ectopic neurons in the subcortical white matter, often containing neurofibrillary tangles, were found in both patients, one of whom presented with epilepsy. Furthermore, I patient showed an unusually high number of ghost tangles in the cerebral cortex. These observations indicate that the Alzheimer kindred FLO10 associated with M239V mutation of presenilin 2 is characterized by some peculiarities of the clinical and neuropathologic phenotype compared to sporadic Alzheimer disease.
引用
收藏
页码:199 / 209
页数:11
相关论文
共 46 条
[1]   Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene [J].
Axelman, K ;
Basun, H ;
Lannfelt, L .
ARCHIVES OF NEUROLOGY, 1998, 55 (05) :698-702
[2]   Are premorbid personality traits linked to the risk of Alzheimer's disease? A case series of subjects with familial mutation [J].
Balestrieri, M ;
Nacmias, B ;
Sorbi, S ;
Marcon, G .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2000, 69 (06) :335-338
[3]   Consensus recommendations for the postmortem diagnosis of Alzheimer's disease [J].
Ball, M ;
Braak, H ;
Coleman, P ;
Dickson, D ;
Duyckaerts, C ;
Gambetti, P ;
Hansen, L ;
Hyman, B ;
Jellinger, K ;
Markesbery, W ;
Perl, D ;
Powers, J ;
Price, J ;
Trojanowski, JQ ;
Wisniewski, H ;
Phelps, C ;
Khachaturian, Z .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :S1-S2
[4]   PHENOTYPIC HETEROGENEITY IN FAMILIAL ALZHEIMERS-DISEASE - A STUDY OF 24 KINDREDS [J].
BIRD, TD ;
SUMI, SM ;
NEMENS, EJ ;
NOCHLIN, D ;
SCHELLENBERG, G ;
LAMPE, TH ;
SADOVNICK, A ;
CHUI, H ;
MINER, GW ;
TINKLENBERG, J .
ANNALS OF NEUROLOGY, 1989, 25 (01) :12-25
[5]   Wide range in age of onset for chromosome 1-related familial Alzheimer's disease [J].
Bird, TD ;
LevyLahad, E ;
Poorkaj, P ;
Sharma, V ;
Nemens, E ;
Lahad, A ;
Lampe, TH ;
Schellenberg, GD .
ANNALS OF NEUROLOGY, 1996, 40 (06) :932-936
[6]   FAMILIAL ALZHEIMERS-DISEASE IN AMERICAN DESCENDANTS OF THE VOLGA GERMANS - PROBABLE GENETIC FOUNDER EFFECT [J].
BIRD, TD ;
LAMPE, TH ;
NEMENS, EJ ;
MINER, GW ;
SUMI, SM ;
SCHELLENBERG, GD .
ANNALS OF NEUROLOGY, 1988, 23 (01) :25-31
[7]   IMMUNOHISTOCHEMICAL STAGING OF NEUROFIBRILLARY DEGENERATION IN ALZHEIMERS-DISEASE [J].
BONDAREFF, W ;
HARRINGTON, C ;
WISCHIK, CM ;
HAUSER, DL ;
ROTH, M .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1994, 53 (02) :158-164
[8]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[9]   AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease [J].
BueeScherrer, V ;
Condamines, O ;
MourtonGilles, C ;
Jakes, R ;
Goedert, M ;
Pau, B ;
Delacourte, A .
MOLECULAR BRAIN RESEARCH, 1996, 39 (1-2) :79-88
[10]  
Bugiani O, 2003, J NEUROPATH EXP NEUR, V62, P547